Prosecution Insights
Last updated: August 17, 2026

Examiner: PEFFLEY, MICHAEL F

Tech Center 3700 • Art Units: 3739 3794

This examiner grants 78% of resolved cases

Performance Statistics

77.7%
Allow Rate
+7.7% vs TC avg
1,403
Total Applications
+12.9%
Interview Lift
1264
Avg Prosecution Days
Based on 1364 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
24.5%
§102 Novelty
38.3%
§103 Obviousness
15.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18966575 USER INTERFACE MARKING FOR RF THERAPY Non-Final OA Boston Scientific Neuromodulation Corporation
18747115 METHODS AND ABLATION SYSTEMS FOR BASIVERTEBRAL NERVE ABLATION USING SHORT, HIGH VOLTAGE PULSES Final Rejection Boston Scientific Neuromodulation Corporation
18669660 COMBINATION THERAPY TOOL FOR ONCOLOGY MANAGEMENT Non-Final OA Covidien LP
18784247 END EFFECTOR AND METHOD OF LASER REMOVAL OF COATING FOR APPLYING ELECTRICAL ENERGY Final Rejection Cilag GmbH International
18287013 A Directional Radiofrequency (RF) Ablation Needle Final Rejection BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM
18795652 EXPANDABLE ELECTRODE ASSEMBLY COMPRISING EXTENDED DISTAL END FOR A MEDICAL CATHETER Non-Final OA Biosense Webster (Israel) Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month